Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2007
|
| gptkbp:ATCCode |
C07AB12
|
| gptkbp:CASNumber |
99200-09-6
|
| gptkbp:chemicalFormula |
C22H25F2NO4
|
| gptkbp:contraindication |
heart block
severe bradycardia severe hepatic impairment |
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:drugClass |
beta blocker
|
| gptkbp:eliminatedIn |
urine
feces |
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericName |
gptkb:nebivolol
|
| gptkbp:halfLife |
12 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bystolic
|
| gptkbp:indication |
high blood pressure
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Allergan
|
| gptkbp:mechanismOfAction |
beta-1 adrenergic receptor antagonist
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness fatigue headache |
| gptkbp:synonym |
gptkb:nebivolol_hydrochloride
|
| gptkbp:usedFor |
hypertension
|
| gptkbp:bfsParent |
gptkb:Forest_Laboratories
|
| gptkbp:bfsLayer |
7
|